In one aspect, the present invention features methods for detecting at least one neurological disorder in a patient, the method comprising obtaining a biological sample from the patient; and detecting at least one aberrant human glutamate transporter 2 (EAAT 2) mRNA in the sample as being indicative of the neurological disorder in the patient. In a particular aspect, the invention is useful for detecting amyotrophic lateral sclerosis (ALS) in the patient.

 
Web www.patentalert.com

< Connective tissue growth factor homologs

< Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of alzheimer' s disease

> Diagnostic and screening methods and kits associated with proteolytic activity

> Use of triplex structure DNA in transferring nucleotide sequences

~ 00241